# Pure Cycle Corp: financial statements, quarterly

PCYO · Nasdaq · CIK 276720 · [Utilities](/sectors/utilities.md) · fiscal year ends Aug 31

Pages: [Overview](/companies/pcyo.md) · [Financials](/companies/pcyo/financials.md) · [Filings](/companies/pcyo/filings.md) · [Insiders](/companies/pcyo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pcyo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.4 d](/filings/0001558370-24-015541.md) | [5.4](/filings/0001558370-25-000069.md) | [3.2](/filings/0001558370-25-004631.md) | [7.6](/filings/0001558370-25-009148.md) | [12.6 d](/filings/0001104659-25-110312.md) | [5.8](/filings/0001104659-26-001739.md) | [4.0](/filings/0001104659-26-040879.md) | [5.1](/filings/0001104659-26-081778.md) | [11.2 d](/filings/0001104659-25-110312.md) | [9.1](/filings/0001104659-26-001739.md) | [5.2](/filings/0001104659-26-040879.md) | [8.2](/filings/0001104659-26-081778.md) |
| Cost of revenue | $m | [1.6 d](/filings/0001558370-24-015541.md) | [2.0](/filings/0001558370-25-000069.md) | [1.4](/filings/0001558370-25-004631.md) | [2.7](/filings/0001558370-25-009148.md) | [2.8 d](/filings/0001104659-25-110312.md) | [2.1](/filings/0001104659-26-001739.md) | [2.5](/filings/0001104659-26-040879.md) | [1.9](/filings/0001104659-26-081778.md) | [3.6 d](/filings/0001104659-25-110312.md) | [2.9](/filings/0001104659-26-001739.md) | [2.4](/filings/0001104659-26-040879.md) | [3.9](/filings/0001104659-26-081778.md) |
| Gross profit | $m | [1.8 d](/filings/0001558370-24-015541.md) | [3.3](/filings/0001558370-25-000069.md) | [1.8](/filings/0001558370-25-004631.md) | [4.9](/filings/0001558370-25-009148.md) | [9.8 d](/filings/0001104659-25-110312.md) | [3.7](/filings/0001104659-26-001739.md) | [1.5](/filings/0001104659-26-040879.md) | [3.3](/filings/0001104659-26-081778.md) | [7.6 d](/filings/0001104659-25-110312.md) | [6.3](/filings/0001104659-26-001739.md) | [2.8](/filings/0001104659-26-040879.md) | [4.3](/filings/0001104659-26-081778.md) |
| Operating income | $m | [0.0 d](/filings/0001558370-24-015541.md) | [1.8](/filings/0001558370-25-000069.md) | [(0.4)](/filings/0001558370-25-004631.md) | [3.1](/filings/0001558370-25-009148.md) | [7.8 d](/filings/0001104659-25-110312.md) | [1.7](/filings/0001104659-26-001739.md) | [(1.3)](/filings/0001104659-26-040879.md) | [1.3](/filings/0001104659-26-081778.md) | [5.9 d](/filings/0001104659-25-110312.md) | [4.4](/filings/0001104659-26-001739.md) | [0.3](/filings/0001104659-26-040879.md) | [2.1](/filings/0001104659-26-081778.md) |
| Interest expense | $m | [0.1 d](/filings/0001558370-24-015541.md) | [0.1](/filings/0001558370-25-000069.md) | [0.1](/filings/0001558370-25-004631.md) | [0.1](/filings/0001558370-25-009148.md) | [0.1 d](/filings/0001104659-25-110312.md) | [0.1](/filings/0001104659-26-001739.md) | [0.1](/filings/0001104659-26-040879.md) | [0.1](/filings/0001104659-26-081778.md) | [0.1 d](/filings/0001104659-25-110312.md) | [0.1](/filings/0001104659-26-001739.md) | [0.1](/filings/0001104659-26-040879.md) | [0.2](/filings/0001104659-26-081778.md) |
| Income tax | $m | [0.2 d](/filings/0001558370-24-015541.md) | [0.7](/filings/0001558370-25-000069.md) | [0.0](/filings/0001558370-25-004631.md) | [1.0](/filings/0001558370-25-009148.md) | [2.2 d](/filings/0001104659-25-110312.md) | [1.3](/filings/0001104659-26-001739.md) | [0.3](/filings/0001104659-26-040879.md) | [0.7](/filings/0001104659-26-081778.md) | [2.1 d](/filings/0001104659-25-110312.md) | [1.5](/filings/0001104659-26-001739.md) | [0.4](/filings/0001104659-26-040879.md) | [1.0](/filings/0001104659-26-081778.md) |
| Net income | $m | [1.1 d](/filings/0001558370-24-015541.md) | [2.1](/filings/0001558370-25-000069.md) | [0.1](/filings/0001558370-25-004631.md) | [2.8](/filings/0001558370-25-009148.md) | [6.6 d](/filings/0001104659-25-110312.md) | [3.9](/filings/0001104659-26-001739.md) | [0.8](/filings/0001104659-26-040879.md) | [2.3](/filings/0001104659-26-081778.md) | [6.1 d](/filings/0001104659-25-110312.md) | [4.6](/filings/0001104659-26-001739.md) | [1.1](/filings/0001104659-26-040879.md) | [2.9](/filings/0001104659-26-081778.md) |
| Diluted EPS | $ per share | not reported | [0.09](/filings/0001558370-25-000069.md) | [0.00](/filings/0001558370-25-004631.md) | [0.12](/filings/0001558370-25-009148.md) | not reported | [0.16](/filings/0001104659-26-001739.md) | [0.03](/filings/0001104659-26-040879.md) | [0.09](/filings/0001104659-26-081778.md) | not reported | [0.19](/filings/0001104659-26-001739.md) | [0.05](/filings/0001104659-26-040879.md) | [0.12](/filings/0001104659-26-081778.md) |
| Basic EPS | $ per share | not reported | [0.09](/filings/0001558370-25-000069.md) | [0.00](/filings/0001558370-25-004631.md) | [0.12](/filings/0001558370-25-009148.md) | not reported | [0.16](/filings/0001104659-26-001739.md) | [0.03](/filings/0001104659-26-040879.md) | [0.09](/filings/0001104659-26-081778.md) | not reported | [0.19](/filings/0001104659-26-001739.md) | [0.05](/filings/0001104659-26-040879.md) | [0.12](/filings/0001104659-26-081778.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [26.0](/filings/0001558370-24-015541.md) | [21.8](/filings/0001558370-25-000069.md) | [20.4](/filings/0001558370-25-004631.md) | [20.4](/filings/0001558370-25-009148.md) | [22.1](/filings/0001104659-25-110312.md) | [19.0](/filings/0001104659-26-001739.md) | [16.5](/filings/0001104659-26-040879.md) | [14.4](/filings/0001104659-26-081778.md) | [21.9](/filings/0001104659-26-081778.md) | [17.1](/filings/0001104659-26-001739.md) | [4.8](/filings/0001104659-26-040879.md) | [8.4](/filings/0001104659-26-081778.md) |
| Current assets | $m | [29.7](/filings/0001558370-24-015541.md) | [29.1](/filings/0001558370-24-000303.md) | [26.4](/filings/0001558370-24-004922.md) | [28.6](/filings/0001558370-24-009739.md) | [37.9](/filings/0001104659-25-110312.md) | [28.2](/filings/0001558370-25-000069.md) | [27.0](/filings/0001558370-25-004631.md) | [25.2](/filings/0001558370-25-009148.md) | [31.7](/filings/0001104659-26-081778.md) | [26.3](/filings/0001104659-26-001739.md) | [13.8](/filings/0001104659-26-040879.md) | [15.6](/filings/0001104659-26-081778.md) |
| Total assets | $m | [133](/filings/0001558370-24-015541.md) | [137](/filings/0001558370-24-000303.md) | [135](/filings/0001558370-24-004922.md) | [140](/filings/0001558370-24-009739.md) | [147](/filings/0001104659-25-110312.md) | [150](/filings/0001558370-25-000069.md) | [150](/filings/0001558370-25-004631.md) | [152](/filings/0001558370-25-009148.md) | [162](/filings/0001104659-26-081778.md) | [168](/filings/0001104659-26-001739.md) | [167](/filings/0001104659-26-040879.md) | [176](/filings/0001104659-26-081778.md) |
| Current liabilities | $m | [6.5](/filings/0001558370-24-015541.md) | [8.8](/filings/0001558370-24-000303.md) | [6.4](/filings/0001558370-24-004922.md) | [9.0](/filings/0001558370-24-009739.md) | [9.3](/filings/0001104659-25-110312.md) | [7.9](/filings/0001558370-25-000069.md) | [7.2](/filings/0001558370-25-004631.md) | [7.2](/filings/0001558370-25-009148.md) | [11.6](/filings/0001104659-26-081778.md) | [11.5](/filings/0001104659-26-001739.md) | [9.9](/filings/0001104659-26-040879.md) | [10.2](/filings/0001104659-26-081778.md) |
| Total liabilities | $m | [15.0](/filings/0001558370-24-015541.md) | [17.1](/filings/0001558370-24-000303.md) | [14.8](/filings/0001558370-24-004922.md) | [17.2](/filings/0001558370-24-009739.md) | [17.7](/filings/0001104659-25-110312.md) | [16.1](/filings/0001558370-25-000069.md) | [15.2](/filings/0001558370-25-004631.md) | [15.1](/filings/0001558370-25-009148.md) | [19.5](/filings/0001104659-26-081778.md) | [20.6](/filings/0001104659-26-001739.md) | [17.9](/filings/0001104659-26-040879.md) | [24.4](/filings/0001104659-26-081778.md) |
| Long-term debt | $m | not reported | [6.9](/filings/0001558370-24-000303.md) | [6.9](/filings/0001558370-24-004922.md) | [6.9](/filings/0001558370-24-009739.md) | [6.9](/filings/0001558370-24-015541.md) | [6.7](/filings/0001558370-25-000069.md) | [6.6](/filings/0001558370-25-004631.md) | [6.5](/filings/0001558370-25-009148.md) | [6.4](/filings/0001104659-25-110312.md) | [7.6](/filings/0001104659-26-001739.md) | [6.5](/filings/0001104659-26-040879.md) | [12.7](/filings/0001104659-26-081778.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001558370-24-000303.md) | [0.0](/filings/0001558370-24-004922.md) | [0.0](/filings/0001558370-24-009739.md) | not reported | [0.2](/filings/0001558370-25-000069.md) | [0.3](/filings/0001558370-25-004631.md) | [0.3](/filings/0001558370-25-009148.md) | [0.4](/filings/0001104659-25-110312.md) | [0.4](/filings/0001104659-26-001739.md) | [1.5](/filings/0001104659-26-040879.md) | [1.5](/filings/0001104659-26-081778.md) |
| Shareholders' equity | $m | [118](/filings/0001104659-25-110312.md) | [120](/filings/0001558370-25-004631.md) | [120](/filings/0001558370-25-009148.md) | [123](/filings/0001558370-25-009148.md) | [130](/filings/0001104659-26-081778.md) | [134](/filings/0001104659-26-040879.md) | [134](/filings/0001104659-26-081778.md) | [137](/filings/0001104659-26-081778.md) | [143](/filings/0001104659-26-081778.md) | [147](/filings/0001104659-26-040879.md) | [149](/filings/0001104659-26-081778.md) | [152](/filings/0001104659-26-081778.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-08-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q4 FY2024 (2024-08-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q4 FY2025 (2025-08-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [631 d](/filings/0001558370-24-015541.md) | [(1,228)](/filings/0001558370-25-000069.md) | [(457) d](/filings/0001558370-25-004631.md) | [892 d](/filings/0001558370-25-009148.md) | [3,105 d](/filings/0001104659-25-110312.md) | [5,674](/filings/0001104659-26-001739.md) | [(1,372) d](/filings/0001104659-26-040879.md) | [(428) d](/filings/0001104659-26-081778.md) | [9,290 d](/filings/0001104659-25-110312.md) | [(979)](/filings/0001104659-26-001739.md) | [(4,208) d](/filings/0001104659-26-040879.md) | [3,469 d](/filings/0001104659-26-081778.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | [198](/filings/0001558370-25-000069.md) | [100 d](/filings/0001558370-25-004631.md) | [141 d](/filings/0001558370-25-009148.md) | [142 d](/filings/0001104659-25-110312.md) | [108](/filings/0001104659-26-001739.md) | [193 d](/filings/0001104659-26-040879.md) | [22.0 d](/filings/0001104659-26-081778.md) | [74.0 d](/filings/0001104659-25-110312.md) | not reported | not reported | [79.0 d](/filings/0001104659-26-081778.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-11-30) | Q2 FY2023 (2023-02-28) | Q3 FY2023 (2023-05-31) | Q1 FY2024 (2023-11-30) | Q2 FY2024 (2024-02-29) | Q3 FY2024 (2024-05-31) | Q1 FY2025 (2024-11-30) | Q2 FY2025 (2025-02-28) | Q3 FY2025 (2025-05-31) | Q1 FY2026 (2025-11-30) | Q2 FY2026 (2026-02-28) | Q3 FY2026 (2026-05-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [24.1](/filings/0001558370-24-000303.md) | [24.1](/filings/0001558370-24-004922.md) | [24.2](/filings/0001558370-24-009739.md) | [24.2](/filings/0001558370-25-000069.md) | [24.1](/filings/0001558370-25-004631.md) | [24.1](/filings/0001558370-25-009148.md) | [24.2](/filings/0001104659-26-001739.md) | [24.2](/filings/0001104659-26-040879.md) | [24.1](/filings/0001104659-26-081778.md) | [24.2](/filings/0001104659-26-001739.md) | [24.2](/filings/0001104659-26-040879.md) | [24.2](/filings/0001104659-26-081778.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 24,097,370 at 2026-07-06, from the cover of the [10-Q filed 2026-07-08](/filings/0001104659-26-081778.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.